MRTX

Mirati Therapeutics, Inc. Common Stock

Delisted

MRTX was delisted on the 22nd of January, 2024.

49 hedge funds and large institutions have $204M invested in Mirati Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-2
Holders Change %
-3.92%
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
16
Reduced
11
Closed
15
Calls
$2.47M
Puts
$874K
Net Calls
+$1.59M
Net Calls Change
+$1.61M
Name Holding Trade Value Shares
Change
Shares
Change %
SM
51
Sabby Management
Florida
-$921K -255,100 Closed
Alyeska Investment Group
52
Alyeska Investment Group
Illinois
-$893K -244,574 Closed
HP
53
Hikari Power
Japan
-$365K -100,000 Closed
Goldman Sachs
54
Goldman Sachs
New York
-$359K -98,251 Closed
LP
55
LMR Partners
United Kingdom
-$236K -64,760 Closed
PP
56
Paloma Partners
Connecticut
-$207K -56,650 Closed
RPAM
57
Rhenman & Partners Asset Management
Sweden
-$183K -50,000 Closed
CS
58
Credit Suisse
Switzerland
-$161K -44,217 Closed
AQR Capital Management
59
AQR Capital Management
Connecticut
-$97K -26,464 Closed
TRCT
60
Tower Research Capital (TRC)
New York
-$62K -16,793 Closed
Connor, Clark & Lunn Investment Management (CC&L)
61
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$58K -15,900 Closed
CA
62
Corrado Advisors
New Jersey
-$37K -10,000 Closed